Skip to main content
Caplight Logo









FullStem Co., Ltd.

FullStem Co., Ltd.

Private
JapanHealthcare & Life Scienceshttps://fullstem.co.jp/

Last Round

Series A

Aug 30, 2024

Est. Valuation

$10M

Total Funding Raised

$960,000

Company Overview

FullStem Co., Ltd. operates in Healthcare & Life Sciences and is based in Japan. Its latest recorded funding round was a Series A round in August 2024.

FullStem Co., Ltd. is a biotechnology company that develops and sells automated mass culture systems for stem cells using non-woven fabric scaffolds for regenerative medicine applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

FullStem Co., Ltd. Comparables

Compare FullStem Co., Ltd. with similar companies based on industry and business-model similarity.

FullStem Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scinus Cell Expansion
83%
Cell X Technologies
80%
Limula
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

FullStem Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 30, 2024
VC RoundApr 8, 2024
SeedNov 12, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

FullStem Co., Ltd. Investors

Notable investors and investment history

FullStem Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

FullStem Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about FullStem Co., Ltd.'s valuation, stock price, and market status.

Is FullStem Co., Ltd. a public or private company?

FullStem Co., Ltd. is a private company.

What is the current stock price of FullStem Co., Ltd.?

FullStem Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks FullStem Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is FullStem Co., Ltd. worth (valuation)?

FullStem Co., Ltd.'s valuation is estimated at $10.0M based on funding round data.

Can I buy FullStem Co., Ltd. stock?

FullStem Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was FullStem Co., Ltd.'s last funding round?

FullStem Co., Ltd.'s most recent funding round was Series A on August 30, 2024.

Who are the main investors in FullStem Co., Ltd.?

Key investors in FullStem Co., Ltd. include Okinawa Development Finance Corporation, BORベンチャーファンド1号投資事業有限責任組合.

Will FullStem Co., Ltd. IPO soon?

No public IPO plans have been announced for FullStem Co., Ltd..

How can I track FullStem Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in FullStem Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersJapan
Year Founded2016
Last FundingAug 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?